Increased oxidative stress and imbalance dynamic thiol–disulfide homeostasis in Rosacea



    Table of Contents ORIGINAL ARTICLE Year : 2022  |  Volume : 16  |  Issue : 4  |  Page : 120-124

Increased oxidative stress and imbalance dynamic thiol–disulfide homeostasis in Rosacea

Eray M Guler1, Beyza N Ozkan2, Nazan Yilmaz3, Fatma P Ozgen4, Nazan S Taslidere5, Selman Aktas6, Ozlem Su Kucuk4
1 Department of Medical Biochemistry, Hamidiye Faculty of Medicine, University of Health Sciences Turkey, Uskudar, Turkey; Department of Medical Biochemistry, Haydarpasa Numune Health Application and Research Center, University of Health Sciences Turkey, Uskudar, Turkey
2 Department of Medical Biochemistry, Haydarpasa Numune Health Application and Research Center, University of Health Sciences Turkey, Uskudar, Turkey
3 Dermatology Clinic, Liv Hospital, Ulus, Turkey
4 Department of Dermatology, Bezmialem Vakif University, Fatih, Turkey
5 Department of Dermatology, Demiroglu Bilim University, Fatih, Turkey
6 Department of Biostatistics, Hamidiye Faculty of Medicine, University of Health Sciences Turkey, Uskudar, Istanbul, Turkey

Date of Submission01-Aug-2022Date of Decision25-Aug-2022Date of Acceptance01-Sep-2022Date of Web Publication28-Nov-2022

Correspondence Address:
Eray M Guler
Department of Medical Biochemistry, Hamidiye Faculty of Medicine, University of Health Sciences Turkey, Uskudar, Istanbul
Turkey
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/tjd.tjd_96_22

Rights and Permissions

Background: Rosacea is a chronic progressive inflammatory disease and characterized by facial erythema, telangiectasias, papules, and pustules. The disease is more common in women than in men while affecting 2%–10% of the population. Though the pathogenesis of rosacea is not fully understood, oxidative stress is one of the asserted pathogenic factors. In this study, we purposed to assess the oxidative stress and thiol–disulfide homeostasis (TDH) in rosacea disease. Materials and Methods: Forty patients with rosacea and 40 healthy people as a control group, both in ages of 18–70 years, with the same demographic characteristics were included, who were applied to the Istanbul Training and Research Hospital Dermatology Clinic. Serum total antioxidant status (TAS), total oxidant status (TOS), total thiol (TT), and native thiol (NT) levels were evaluated by using the automated and spectrophotometric method according to Erel and Neselioglu. Oxidative stress index (OSI), disulfide (DIS) levels, and NT/TT, DIS/TT and DIS/NT percentages were calculated mathematically. Results: TAS, TT, and NT levels were decreased in rosacea patients compared with the healthy group, whereas TOS, OSI, and DIS levels were increased. Additionally, although DIS/TT and DIS/NT percentages were higher in patients, NT/TT ratio was lower than the healthy group, and these findings were statistically significant (p < 0.001). Conclusion: The results showed that oxidative stress levels were increased in rosacea patients and TDH shifted toward DIS formation. It has been thought that oxidative stress is a parameter that may be utilized in the clinical evaluation of the disease.

Keywords: Disulfide, inflammation, oxidative stress, rosacea, skin disease, thiol


How to cite this article:
Guler EM, Ozkan BN, Yilmaz N, Ozgen FP, Taslidere NS, Aktas S, Su Kucuk O. Increased oxidative stress and imbalance dynamic thiol–disulfide homeostasis in Rosacea. Turk J Dermatol 2022;16:120-4
How to cite this URL:
Guler EM, Ozkan BN, Yilmaz N, Ozgen FP, Taslidere NS, Aktas S, Su Kucuk O. Increased oxidative stress and imbalance dynamic thiol–disulfide homeostasis in Rosacea. Turk J Dermatol [serial online] 2022 [cited 2022 Nov 29];16:120-4. Available from: https://www.tjdonline.org/text.asp?2022/16/4/120/362034

Dr. Guler and Dr. Ozkan contributed equally to this work

  Introduction Top

Rosacea is a chronic inflammatory skin disease that is thought to affect 2%–10% of the population and is more common in women than in men.[1] The disease features are flushing, nontransient erythema, papules/pustules, telangiectasia, and phymatous changes.[2] Secondary symptoms such as burning or stinging sensation, plaque, a dry appearance of the skin, edema, ocular manifestations, and phymatous changes could sight in patients.[3] There are four different clinical subtypes related to the disease according to the patterns of physical symptoms.[4] These subtypes are phymatous rosacea, erythematotelangiectatic rosacea, papulopustular rosacea, and ocular rosacea.[5]

Although the pathogenesis of rosacea is not exactly comprehended, some pathogenic factors have been asserted to be. In addition to these, environmental triggers such as ultraviolet irradiation, temperature changes, alcohol, physical activity, foods, and chemicals are also thought to be related.[6] The disease includes local inflammatory responses in the skin against cutaneous microorganisms such as Demodex folliculorum and Demodex brevis and changes in the lymphatic vascular systems.[7] Recent studies have shown that rosacea, which is an inflammatory disease, is relevant to the generation of reactive oxygen species (ROS) released by inflammatory cells.[8]

The imbalance between the number of present antioxidant molecules and the overproduction of ROS is defined as oxidative stress.[9] The oxidation of proteins and lipids occurs as a result of the deactivation of natural defenses by oxidative stress. As a result of the changes in the lipid balance, inflammation occurs with the release of other inflammatory mediators such as cytokines.[10] Dynamic thiol–disulfide homeostasis (TDH), which is the ratio between the thiol and disulfide (DIS) parameters, is another parameter that indicates the balance of oxidant–antioxidant status.[11] The dynamic thiol-disulfide balance could be maintained by the reduction of thiol groups converted to DIS structures back to thiol groups.[12] This homeostasis is involved in important functions such as the regulation of enzymatic activity, apoptosis, signal transduction, and antioxidant protection.[13] The disruption of dynamic TDH and also oxidative stress causes many diseases such as asthma,[14] inflammatory diseases, cardiovascular diseases,[15] diabetes,[16] rheumatoid arthritis,[17] kidney diseases,[18] and cancer.[19] As in many inflammatory diseases, oxidative stress is thought to be one of the important factors for the pathophysiology of rosacea disease.[20] We purposed to investigate and evaluate the levels of oxidative stress that are important to understand the pathogenesis of the disease in patients with rosacea.

  Materials and Methods Top

Design of study

The persons were selected from those diagnosed with rosacea according to the criteria of the United States National Rosacea Society,[21] who were applied to the Istanbul Training and Research Hospital Dermatology Clinic. The Fitzpatrick classification was utilized to identify the skin types of patients.[22] The number of volunteers was calculated as a minimum of 80 volunteers by power analysis at the α = 0.05 significance level to obtain 80% power in the study. Forty patients with rosacea ages of 18–70 years and 40 healthy volunteers as a control group with the same demographic characteristics were included, who stated that they would participate in the study by reading and signing the consent form. The patients or persons having dermatological or systemic; acute or chronic inflammatory disease affecting oxidative stress parameters, kidney disease, liver disease, neurodegenerative disease, cancer, the use of drugs that have an effect on the cardiovascular system, and smokers would be excluded. It was approved by the decision of the Clinical Research Ethics Committee of Hamidiye University of Health Sciences, numbered 22/167, and dated 25/03/2022.

Blood sample

Blood samples of volunteers were taken into sterile gel tubes with a clot activator and were centrifuged at 3000× g for 10 min. Until the specified number of individuals was reached and biochemical analysis was performed, separated serum samples were stored at −80°C.

Measurement of oxidative stress levels

Total antioxidant status (TAS) was measured according to the Erel’s fully automatic photometric method.[23] The presence of antioxidants is reduced to the blue–green color of the 2,2′-Azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS+; Sigma, St. Louis, USA) radical that the main principle of this test. The color change resulting from the reaction was measured with a multimode plate reader at 600 nm wavelength. Ascorbic acid was used as a standard in the measurement. Results were expressed as mmol ascorbic acid equivalent per liter (mmol Ascorbic Acid Eq./L).

Total oxidant status (TOS) is based on the principle that xylenol orange forms a colored complex by adding a ferric ion-containing reagent in an acidic condition, according to the photometric method of Erel.[24] The Fe2+-o-dianisidine complex is converted to Fe3+ ion with the oxidants in the sample by oxidizing. Color intensity was measured spectrophotometrically at a wavelength of 571/658 nm in relation to the total amount of oxidant molecules present. H2O2 (Sigma Aldrich, Germany) was used for calibration, and results were expressed as H2O2 equivalent per liter (μmol H2O2 Eq./L). Oxidative stress index (OSI) was obtained by dividing serum TOS and TAS levels.

Measurement of TDH

Serum TDH was measured by the photometric method according to Erel and Neselioglu.[25] Free thiol groups from reducible DIS bonds are formed by sodium borohydride, which in excess is removed with formaldehyde, followed by a reaction with 5,5′-dithiobis-(2-nitrobenzoic) acid (DTNB; Sigma, St. Louis, USA) to reduce thiol groups. In this way, the total thiol (TT) containing the reduced and native thiol (NT) groups were determined. Half the difference between TT and NT groups for dynamic DIS content, DIS/TT, DIS/NT, and NT/TT percentages were calculated with mathematical formulas.

Statistical analysis

Categorical variables were expressed as numbers and percentages, and numerical variables were also as mean ± standard deviation. The Mann–Whitney U test and the Student’s t-test were utilized for the comparison of two independent groups. The Statistical Package for Social Sciences (SPSS, New York, USA) program 25.0 version was used for all statistical analysis.

  Results Top

In this study, the groups were expressed in terms of age (39 ± 10.10 years), gender (68 female + 32 male), and body mass index (25 ± 2.95), and there was no statistically significant difference between the groups. The participants’ demographic characteristics were given in [Table 1].

According to the Fitzpatrick classification of skin types, skin type 2 was the most common in the individuals participating in our study. However, the erythematotelangiectatic subtype was seen in the majority of rosacea patients, followed by phymatous and papulopustular in [Table 2].

Although TOS and OSI levels were higher in rosacea patients than in the control group with increased oxidative stress, TAS levels were found to be lower. Dynamic TDH as an oxidative stress parameter is given in [Table 3]. The DIS levels, which indicate oxidative damage, were raised in patients compared with controls. Additionally, NT and TT levels, which are indicators of antioxidant capacity, were also statistically significantly lower than the control group (p < 0.001).

Table 3: According to the control, comparing oxidative stress parameters in rosacea patients

Click here to view

  Discussion Top

Rosacea, which is a progressive inflammatory disease, is characterized by facial erythema, pustules, papules, and telangiectasias. The disease occurs between the ages of 30–50 and shows similar incidence rates in men and women additionally.[26] It is assumed that rosacea is associated with different dysregulated nervous, immune, vascular systems, and the disease could be triggered by microbes, temperature changes, ultraviolet radiation, nutrition, hormones, and psychosocial stress, inducing an enhanced innate immune response.[27] Oxidative stress is the formation of excess ROS at levels higher than the body’s antioxidant capacity. Recent studies have shown that oxidative stress is related to oxidative tissue damage, vascular changes, and inflammation in rosacea and has an important role in the pathophysiology of the disease.[28] Thiol levels are one of the parameters that give information about oxidative stress and also are valuable for understanding the underlying causes of the rosacea disease. In this study, the dynamic TDH and oxidative stress levels of rosacea patients were purposed to evaluate.

Recent studies have suggested that oxidative stress conduces to the pathophysiology of skin diseases, which is more sensitive to damage caused by ROS than other tissues. The presence of ROS destroys collagen and inactivates tissue inhibitors of matrix metalloproteinases.[29] In the study by Tisma et al., serum total antioxidant capacity in rosacea patients was lower than in the healthy group, whereas serum peroxide levels were higher in the patients.[30] Erdogan et al. have shown that serum TAS levels decreased in rosacea patients compared with healthy volunteers as serum oxidant levels increased.[31] This study has shown that antioxidant levels decreased depending on the increase in ROS level in the patients, and TOS and OSI increased compared with healthy volunteers. Our findings were consistent with the literature.

Although NT simply means nonreduced thiol, TT consists of both reduced and nonreduced thiols, which include both intracellular and extracellular thiols.[32] Thiols contain sulfhydryl residues as the class of organic sulfur derivatives. It is entrusted with antioxidant defense and also has many functions in biological systems. The level of DIS bonds is an early indicator of protein oxidation caused by ROS.[33] Thiol groups are oxidized to form DIS bonds with the presence of oxidants, thereby plasma thiol levels were decreased. Dynamic TDH is defined as the reduction of formed DIS bonds back to reduced thiol groups.[34] The shift of TDH to DIS formation causes pathologies in the structure, and functions of many organs so result in the emergence of various diseases.[35],[36]

There are few studies investigating dynamic TDH in rosacea patients in the literature. Sener et al. found that serum DIS levels were higher in rosacea patients compared to the control group. It was determined that the dynamic TDH shifted toward DIS formation with the rosacea disease. Additionally, DIS/TT and DIS/NT ratios were found to be higher in patients compared with the healthy control group, whereas NT/TT ratios were found to be lower.[37] TDH has been investigated in an inflammatory skin disease named lichen planus. TT and NT levels were compared with the healthy control group and found to be lower in these patients.[38] Aksoy and Kirmit examined the levels of thiol and DIS in psoriasis, which is a chronic inflammatory disease of the skin. In this study, serum TT and NT levels of psoriasis patients were detected to be lower compared with the healthy control group, whereas serum DIS levels were found to be higher.[39] Pektas et al. found DIS levels to be higher in psoriasis patients than in the control group, whereas TT and NT levels were lower in patients than the control group. The percents of DIS/NT and DIS/TT were found to be lower compared with the healthy control. However, the percents of NT/TT were higher in the patient than in the healthy group.[40] In this study, TT and NT levels were decreased in rosacea patients than in the healthy control group, whereas DIS levels were increased. DIS/NT and DIS/TT percentages were higher in rosacea patients compared with controls, whereas NT/TT ratios were lower. TDH parameters are similar to studies in patients with rosacea and other inflammatory skin diseases in the literature.

The number of patients in the study was not sufficient and the study participants might not be representative of patients from the general population. In addition, clinical scoring of the disease is among the limitations of the study because of a semi-quantitative evaluation method.

  Conclusion Top

We investigated OSI and dynamic TDH, which are the oxidative stress biomarkers that could be utilized in understanding the pathogenesis of rosacea. The results have been shown that TOS, OSI, and DIS levels increased in patients with rosacea, whereas the levels of TAS, TT, and NT, which are involved in antioxidant defense, decreased. It has been observed that TDH shifts toward DIS formation in patients with rosacea. It is thought that our results could be a guide in understanding the factors that cause the disease and in the development of current treatments.

Acknowledgments

None declared.

Financial support and sponsorship

None.

Conflicts of interest

There are no conflicts of interest.

 

  References Top
1.Johnson SM, Berg A, Barr C Managing rosacea in the clinic: From pathophysiology to treatment—A review of the literature. J Clin Aesthet Dermatol 2020;13:17-22.  Back to cited text no. 1
    2.Zhang H, Tang K, Wang Y, Fang R, Sun Q Rosacea treatment: Review and update. Dermatol Ther (Heidelb) 2021;11:13-24.  Back to cited text no. 2
    3.van Zuuren EJ Rosacea. N Engl J Med 2017;377:1754-64.  Back to cited text no. 3
    4.Schaller M, Almeida LMC, Bewley A, Cribier B, Del Rosso J, Dlova NC, et al. Recommendations for rosacea diagnosis, classification and management: Update from the global rosacea consensus 2019 panel. Br J Dermatol 2020;182:1269-76.  Back to cited text no. 4
    5.Steinhoff M, Schauber J, Leyden JJ New insights into rosacea pathophysiology: A review of recent findings. J Am Acad Dermatol 2013;69:S15-26.  Back to cited text no. 5
    6.Gether L, Overgaard LK, Egeberg A, Thyssen JP Incidence and prevalence of rosacea: A systematic review and meta-analysis. Br J Dermatol 2018;179:282-9.  Back to cited text no. 6
    7.Reinholz M, Ruzicka T, Steinhoff M, Schaller M, Gieler U, Schöfer H, et al. Pathogenese und klinik der rosazea als schlüssel für eine symptomorientierte therapie. J Dtsch Dermatol Ges 2016;14 Suppl 6:4-16.  Back to cited text no. 7
    8.Jones D Reactive oxygen species and rosacea. Cutis2004;74:17-34.  Back to cited text no. 8
    9.Cannavò SP, Riso G, Casciaro M, Di Salvo E, Gangemi S Oxidative stress involvement in psoriasis: A systematic review. Free Radic Res 2019;53:829-40.  Back to cited text no. 9
    10.Jabbehdari S, Memar OM, Caughlin B, Djalilian AR Update on the pathogenesis and management of ocular rosacea: An interdisciplinary review. Eur J Ophthalmol 2021;31:22-33.  Back to cited text no. 10
    11.Uysal P, Avcil S, Neşelioğlu S, Biçer C, Çatal F Association of oxidative stress and dynamic thiol-disulphide homeostasis with atopic dermatitis severity and chronicity in children: A prospective study. Clin Exp Dermatol 2018;43:124-30.  Back to cited text no. 11
    12.Emre S, Kalkan G, Erdoğan S, Aktaş A, Ergin M Dynamic thiol/disulfide balance in patients with seborrheic dermatitis: A case-control study. Saudi J Med Med Sci 2020;8:12-6.  Back to cited text no. 12
    13.Biswas S, Chida AS, Rahman I Redox modifications of protein-thiols: Emerging roles in cell signaling. Biochem Pharmacol 2006;71:551-64.  Back to cited text no. 13
    14.Nar R, Çalış AG Assessment of dynamic thiol/disulfide homeostasis in patients with asthma. J Lab Med 2018;42:99-104.  Back to cited text no. 14
    15.Bilici SR, Ersoz GN, Omma T Association of dietary factors and dynamic thiol/disulphide homeostasis in subjects with coronary artery disease. Endocrine Abstracts Bioscientifica2018;56.  Back to cited text no. 15
    16.Ates I, Kaplan M, Yuksel M, Mese D, Alisik M, Erel Ö, et al. Determination of thiol/disulphide homeostasis in type 1 diabetes mellitus and the factors associated with thiol oxidation. Endocrine 2016;51:47-51.  Back to cited text no. 16
    17.Tuzcu A, Baykara RA, Omma A, Acet GK, Dogan E, Cure MC, et al. Thiol/disulfide homeostasis in patients with rheumatoid arthritis. Rom J Intern Med 2019;57:30-6.  Back to cited text no. 17
    18.Sonmez MG, Kozanhan B, Deniz ÇD, Iyisoy MS, Kilinc MT, Ecer G, et al. Dynamic thiol/disulfide homeostasis as a novel indicator of oxidative stress in patients with urolithiasis. Investig Clin Urol 2019;60:258-66.  Back to cited text no. 18
    19.Sezgin B, Kinci MF, Pirinççi F, Camuzcuoğlu A, Erel Ö, Neşelioğlu S, et al. Thiol-disulfide status of patients with cervical cancer. J Obstet Gynaecol Res 2020;46:2423-9.  Back to cited text no. 19
    20.Takci Z, Bilgili SG, Karadag AS, Kucukoglu ME, Selek S, Aslan M Decreased serum paraoxonase and arylesterase activities in patients with rosacea. J Eur Acad Dermatol Venereol 2015;29:367-70.  Back to cited text no. 20
    21.Wilkin J, Dahl M, Detmar M, Drake L, Liang MH, Odom R, et al; National Rosacea Society Expert Committee. Standard grading system for rosacea: Report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol 2004;50:907-12.  Back to cited text no. 21
    22.Astner S, Anderson RR Skin phototypes 2003. J Invest Dermatol 2004;122:xxx-xxxi.  Back to cited text no. 22
    23.Erel O A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37:112-9.  Back to cited text no. 23
    24.Erel O A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38:1103-11.  Back to cited text no. 24
    25.Erel O, Neselioglu S A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem 2014;47:326-32.  Back to cited text no. 25
    26.Duman N, Ersoy Evans S, Atakan N Rosacea and cardiovascular risk factors: A case control study. J Eur Acad Dermatol Venereol 2014;28:1165-9.  Back to cited text no. 26
    27.Rainer BM, Kang S, Chien AL Rosacea: Epidemiology, pathogenesis, and treatment. Dermatoendocrinol 2017;9:e1361574.  Back to cited text no. 27
    28.Jones DA Rosacea, reactive oxygen species, and azelaic acid. J Clin Aesthet Dermatol 2009;2:26-30.  Back to cited text no. 28
    29.Bakar Ö, Demirçay Z, Yuksel M, Haklar G, Sanisoglu Y. The effect of azithromycin on reactive oxygen species in rosacea. Clin Exp Dermatol2007;32:197-200.  Back to cited text no. 29
    30.Tisma VS, Basta-Juzbasic A, Jaganjac M, Brcic L, Dobric I, Lipozencic J, et al. Oxidative stress and ferritin expression in the skin of patients with rosacea. J Am Acad Dermatol 2009;60:270-6.  Back to cited text no. 30
    31.Erdogan HK, Bulur I, Kocaturk E, Saracoglu ZN, Alatas O, Bilgin M Advanced oxidation protein products and serum total oxidant/antioxidant status levels in rosacea. Postepy Dermatol Alergol 2018;35:304-8.  Back to cited text no. 31
    32.Turell L, Radi R, Alvarez B The thiol pool in human plasma: The central contribution of albumin to redox processes. Free Radic Biol Med 2013;65:244-53.  Back to cited text no. 32
    33.Sen CK, Packer L Thiol homeostasis and supplements in physical exercise. Am J Clin Nutr 2000;72:653S-69S.  Back to cited text no. 33
    34.Hadwan MH, Alsalman AS, Almashhedy LA, Altaee AH, Hadwan AM Fluorometric assessment of sulfhydryl oxidase activity: Optimization by response surface methodology. J Fluoresc 2022;32:381-8.  Back to cited text no. 34
    35.Erenler AK, Yardan T Clinical utility of thiol/disulfide homeostasis. Clin Lab 2017;63:867-70.  Back to cited text no. 35
    36.Jones DP, Liang Y Measuring the poise of thiol/disulfide couples in vivo. Free Radic Biol Med 2009;47:1329-38.  Back to cited text no. 36
    37.Sener S, Akbas A, Kilinc F, Baran P, Erel O, Aktas A Thiol/disulfide homeostasis as a marker of oxidative stress in rosacea: A controlled spectrophotometric study. Cutan Ocul Toxicol 2019;38:55-8.  Back to cited text no. 37
    38.Kalkan G, Emre S, Alisik M, Aktaş A, Baran P Dynamic thiol/disulfide homeostasis in patients with lichen planus. J Clin Lab Anal 2019;33:e22642.  Back to cited text no. 38
    39.Aksoy M, Kirmit A Thiol/disulphide balance in patients with psoriasis. Postepy Dermatol Alergol 2020;37:52-5.  Back to cited text no. 39
    40.Demir Pektas S, Pektas G, Tosun K, Dogan G, Neselioglu S, Erel O Evaluation of erythroid disturbance and thiol-disulphide homeostasis in patients with psoriasis. Biomed Res Int 2018;2018: 9548252.  Back to cited text no. 40
    

 
 


  [Table 1], [Table 2], [Table 3]
  Top

留言 (0)

沒有登入
gif